Natixis
SMTI icon

Natixis’s Sanara MedTech SMTI Stock Holding History

Natixis’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.01M Buy
+28,839
New +$914K ﹤0.01% 722

Other funds holding SMTI

Transmarket Holdings
Transmarket Holdings Chicago, Illinois $179M AUM 32.06% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Hill Island Financial
Hill Island Financial Grand Rapids, Michigan $481M AUM 18.93% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Natixis's SMTI Position: Q3 2026 in Review

Natixis opened a new position in Sanara MedTech (SMTI) in Q3 2026: 28,839 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #722 among its holdings.

26 funds tracked by Wall St. Rank hold SMTI as of Q3 2026.

  • Natixis held 28,839 shares of Sanara MedTech worth $1.01M as of Q3 2026.
  • Sanara MedTech was a new Natixis position in Q3 2026.
  • Sanara MedTech made up ﹤0.01% of Natixis's portfolio in Q3 2026, its #722 holding.
  • 26 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2026.

Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.